208 related articles for article (PubMed ID: 22404917)
1. In silico optimization of atrial fibrillation-selective sodium channel blocker pharmacodynamics.
Aguilar-Shardonofsky M; Vigmond EJ; Nattel S; Comtois P
Biophys J; 2012 Mar; 102(5):951-60. PubMed ID: 22404917
[TBL] [Abstract][Full Text] [Related]
2. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
[TBL] [Abstract][Full Text] [Related]
3. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.
Burashnikov A; Di Diego JM; Zygmunt AC; Belardinelli L; Antzelevitch C
Circulation; 2007 Sep; 116(13):1449-57. PubMed ID: 17785620
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
Burashnikov A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates.
Comtois P; Sakabe M; Vigmond EJ; Munoz M; Texier A; Shiroshita-Takeshita A; Nattel S
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1489-504. PubMed ID: 18676686
[TBL] [Abstract][Full Text] [Related]
6. Atrial-selective sodium channel block for the treatment of atrial fibrillation.
Burashnikov A; Antzelevitch C
Expert Opin Emerg Drugs; 2009 Jun; 14(2):233-49. PubMed ID: 19466903
[TBL] [Abstract][Full Text] [Related]
7. Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation.
Burashnikov A; Di Diego JM; Zygmunt AC; Belardinelli L; Antzelevitch C
Ann N Y Acad Sci; 2008 Mar; 1123():105-12. PubMed ID: 18375582
[TBL] [Abstract][Full Text] [Related]
8. The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.
Burashnikov A; Barajas-Martinez H; Hu D; Robinson VM; Grunnet M; Antzelevitch C
J Cardiovasc Pharmacol; 2020 Aug; 76(2):164-172. PubMed ID: 32453071
[TBL] [Abstract][Full Text] [Related]
9. Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
Burashnikov A; Belardinelli L; Antzelevitch C
J Pharmacol Exp Ther; 2012 Jan; 340(1):161-8. PubMed ID: 22005044
[TBL] [Abstract][Full Text] [Related]
10. Effect of Na+-channel blockade on the three-dimensional substrate of atrial fibrillation in a model of endo-epicardial dissociation and transmural conduction.
Gharaviri A; Verheule S; Eckstein J; Potse M; Krause R; Auricchio A; Kuijpers NHL; Schotten U
Europace; 2018 Nov; 20(suppl_3):iii69-iii76. PubMed ID: 30476060
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation.
Chandra P; Rosen TS; Yeom ZH; Lee K; Kim HY; Danilo P; Rosen MR
Europace; 2004 Sep; 6(5):384-91. PubMed ID: 15294262
[TBL] [Abstract][Full Text] [Related]
12. Atrial-selective sodium channel blockers: do they exist?
Burashnikov A; Antzelevitch C
J Cardiovasc Pharmacol; 2008 Aug; 52(2):121-8. PubMed ID: 18670368
[TBL] [Abstract][Full Text] [Related]
13. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
Aguilar M; Nattel S
J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
[TBL] [Abstract][Full Text] [Related]
14. AZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dog.
Burashnikov A; Zygmunt AC; Di Diego JM; Linhardt G; Carlsson L; Antzelevitch C
J Cardiovasc Pharmacol; 2010 Jul; 56(1):80-90. PubMed ID: 20386458
[TBL] [Abstract][Full Text] [Related]
15. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
[TBL] [Abstract][Full Text] [Related]
16. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling.
Tsujimae K; Murakami S; Kurachi Y
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H793-800. PubMed ID: 18055524
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches for pharmacological management of atrial fibrillation.
Ehrlich JR; Nattel S
Drugs; 2009; 69(7):757-74. PubMed ID: 19441867
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.
Burashnikov A; Di Diego JM; Barajas-Martínez H; Hu D; Cordeiro JM; Moise NS; Kornreich BG; Belardinelli L; Antzelevitch C
Circ Heart Fail; 2014 Jul; 7(4):627-33. PubMed ID: 24874201
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model.
Kneller J; Kalifa J; Zou R; Zaitsev AV; Warren M; Berenfeld O; Vigmond EJ; Leon LJ; Nattel S; Jalife J
Circ Res; 2005 Mar; 96(5):e35-47. PubMed ID: 15731458
[TBL] [Abstract][Full Text] [Related]
20. PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers.
Syeda F; Holmes AP; Yu TY; Tull S; Kuhlmann SM; Pavlovic D; Betney D; Riley G; Kucera JP; Jousset F; de Groot JR; Rohr S; Brown NA; Fabritz L; Kirchhof P
J Am Coll Cardiol; 2016 Oct; 68(17):1881-1894. PubMed ID: 27765191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]